Cochrane Abstracts
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"A Therapeutic‐only Versus Prophylactic Platelet Transfusion Strategy for Preventing Bleeding in Patients With Haematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���������only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_. Accessed 10 June 2023.
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���������only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_. Accessed June 10, 2023.
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���������only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_
A Therapeutic‐only Versus Prophylactic Platelet Transfusion Strategy for Preventing Bleeding in Patients With Haematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation [Internet]. In: Cochrane Abstracts. [cited 2023 June 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���������only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
ID - 439382
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���������only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
